Option Care Health (NASDAQ:OPCH) Upgraded at Wall Street Zen

Wall Street Zen upgraded shares of Option Care Health (NASDAQ:OPCH) from a hold rating to a buy rating in a research note published on Saturday morning.

OPCH has been the topic of a number of other research reports. Bank of America lowered Option Care Health from a “buy” rating to a “neutral” rating and set a $22.00 price objective on the stock. in a research note on Friday, May 1st. Stephens reissued an “equal weight” rating and issued a $24.00 target price (down from $30.00) on shares of Option Care Health in a research note on Friday, July 17th. The Goldman Sachs Group started coverage on shares of Option Care Health in a report on Monday, June 8th. They issued a “neutral” rating and a $22.00 target price on the stock. Weiss Ratings cut shares of Option Care Health from a “hold (c-)” rating to a “sell (d+)” rating in a research note on Thursday, July 23rd. Finally, Deutsche Bank Aktiengesellschaft reiterated a “hold” rating and set a $24.00 price target (down from $26.00) on shares of Option Care Health in a report on Thursday. Seven investment analysts have rated the stock with a Buy rating, six have issued a Hold rating and one has assigned a Sell rating to the company. Based on data from MarketBeat.com, the company currently has an average rating of “Hold” and a consensus price target of $29.92.

Option Care Health Price Performance

OPCH stock opened at $23.70 on Friday. Option Care Health has a 1 year low of $18.01 and a 1 year high of $36.80. The company has a debt-to-equity ratio of 0.91, a quick ratio of 0.98 and a current ratio of 1.47. The stock’s 50 day moving average price is $21.55 and its 200 day moving average price is $26.68. The firm has a market cap of $3.55 billion, a P/E ratio of 17.82, a PEG ratio of 1.38 and a beta of 0.65.

Option Care Health (NASDAQ:OPCH) last announced its earnings results on Wednesday, July 29th. The company reported $0.45 EPS for the quarter, beating analysts’ consensus estimates of $0.43 by $0.02. The firm had revenue of $1.44 billion for the quarter, compared to analysts’ expectations of $1.42 billion. Option Care Health had a return on equity of 18.74% and a net margin of 3.68%.Option Care Health’s quarterly revenue was up 1.9% on a year-over-year basis. During the same quarter in the prior year, the firm earned $0.41 EPS. Option Care Health has set its FY 2026 guidance at 1.850-1.920 EPS. On average, sell-side analysts expect that Option Care Health will post 1.64 earnings per share for the current fiscal year.

Insider Activity

In other Option Care Health news, Director Timothy P. Sullivan acquired 24,154 shares of the stock in a transaction dated Thursday, May 7th. The stock was acquired at an average price of $20.69 per share, with a total value of $499,746.26. Following the completion of the transaction, the director directly owned 73,383 shares in the company, valued at approximately $1,518,294.27. This trade represents a 49.06% increase in their ownership of the stock. The purchase was disclosed in a document filed with the SEC, which is available at the SEC website. 1.70% of the stock is owned by company insiders.

Hedge Funds Weigh In On Option Care Health

Large investors have recently added to or reduced their stakes in the business. Durable Capital Partners LP grew its holdings in Option Care Health by 134.2% in the 2nd quarter. Durable Capital Partners LP now owns 8,237,577 shares of the company’s stock valued at $267,557,000 after buying an additional 4,720,988 shares during the period. Fuller & Thaler Asset Management Inc. lifted its holdings in shares of Option Care Health by 12.1% during the 4th quarter. Fuller & Thaler Asset Management Inc. now owns 6,958,800 shares of the company’s stock worth $221,707,000 after acquiring an additional 752,058 shares during the period. Arrowstreet Capital Limited Partnership boosted its position in shares of Option Care Health by 6.2% in the fourth quarter. Arrowstreet Capital Limited Partnership now owns 4,248,425 shares of the company’s stock worth $135,355,000 after acquiring an additional 247,118 shares during the last quarter. Dimensional Fund Advisors LP boosted its position in shares of Option Care Health by 0.9% in the first quarter. Dimensional Fund Advisors LP now owns 3,876,856 shares of the company’s stock worth $104,368,000 after acquiring an additional 36,208 shares during the last quarter. Finally, Southpoint Capital Advisors LP grew its holdings in Option Care Health by 20.0% in the first quarter. Southpoint Capital Advisors LP now owns 3,600,000 shares of the company’s stock valued at $96,912,000 after purchasing an additional 600,000 shares during the period. 98.05% of the stock is currently owned by hedge funds and other institutional investors.

About Option Care Health

Option Care Health (NASDAQ: OPCH) is a leading provider of home and alternate site infusion services in the United States. The company specializes in the administration of injectable therapies, including antibiotics, nutrition, hydration, immunoglobulin, pain management and specialty pharmaceuticals. Through its nationwide network of infusion pharmacies and nursing professionals, Option Care Health delivers customized care plans and in-home nursing visits to patients managing complex or chronic conditions outside of a hospital setting.

Option Care Health traces its current structure to the completion of its merger with BioScrip in early 2021, combining two of the industry’s most experienced home infusion businesses.